Parachlorella beyerinckii accelerates lead excretion in mice.
The effect of Parachlorella beyerinckii CK-5, previously identified as Chlorella vulgaris, on gastrointestinal absorption of lead was investigated in mice. Female ICR mice aged 7 weeks were orally administered lead acetate solution at doses of 20 mg and 40 mg of lead per mouse, with or without 100 mg of P. beyerinckii powder (BP). The mice were bred for 24 hours. The amount of lead excreted in feces within 24 hours, and the lead levels of the blood, liver and kidney were analyzed by atomic absorption spectrometry. The percentage of total fecal excretion in mice administered BP increased by 27.7% in 20 mg lead administered mice and 17.2% in 40 mg lead administered mice in comparison to control mice, respectively. On the other hand, the lead levels of the blood, liver and kidney of BPadministered mice at 24 hours after lead administration were 48-63% lower as compared with those of control mice. The lead adsorption ability of BP and the pepsin non-digestive residue of BP (dBP) were investigated in vitro. One hundred mg of BP and dBP could adsorb 10.6 mg and 6.0 mg of lead in a 20 mg per 10 mL of lead solution, respectively. The lead absorption abilities of BP and dBP were considered to contribute to the prevention of gastrointestinal absorption of lead and the promotion of the excretion of lead. These results suggested that BP treatment might be useful in animals and humans exposed to lead.
Uchikawa
Takuya
T
Chlorella Industry Co. Ltd, Chikugo, Fukuoka, Japan.
Ueno
Takeyuki
T
Hasegawa
Takashi
T
Maruyama
Isao
I
Kumamoto
Shoichiro
S
Ando
Yotaro
Y
D000284:Administration, Oral; D000327:Adsorption; D000818:Animals; D002708:Chlorella; D005243:Feces / Q000737:chemistry*; D005260:Female; D007668:Kidney / Q000378:metabolism; D007854:Lead / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D013054:Spectrophotometry, Atomic
D007854:Lead